At a glance
ClinicalIndex Comparison RecordN/ACompleted· 81 enrolled
Drug / intervention
Micropulse Laser Trabeculoplasty +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase IV Study of Micropulse Laser Trabeculoplasty Versus Selective Laser Trabeculoplasty for Treatment of Open Angle Glaucoma
In Brief
A clinical study evaluating Micropulse Laser Trabeculoplasty and Selective Laser Trabeculoplasty for Open Angle Glaucoma. Completed, enrolled 81 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the effectiveness of a new laser (called Micropulse Laser Trabeculoplasty or MLT) in the treatment of glaucoma compared to the conventional laser presently used which is called selective laser trabeculoplasty or SLT. Both lasers (SLT and MLT) are used as standard of care in the treatment of open angle glaucoma.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOpen Angle Glaucoma
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedOct 2013
Primary CompletionJul 2017
Study CompletionJul 2017
TodayJul 2026
First PostedOct 8, 2013
Enrollment StartAug 1, 2013
Primary CompletionJul 1, 2017
Study CompletionJul 24, 2017
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 12.7 years ago
Interventions
Micropulse Laser Trabeculoplastydevice
Selective Laser Trabeculoplastydevice